Trial Profile
Comparison of DPP-4 inhibitors, vildagliptin and linagliptin in type 2 diabetes
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 18 Oct 2013 Planned end date (31 Mar 2017) added as reported by University Hospital Medical Information Network - Japan record.
- 12 Apr 2013 New trial record